Top Story

DURABILITY II: Single self-expanding stent linked to sustained outcomes at 3 years

March 30, 2015

Use of a single self-expanding stent up to 20 cm in length in long femoropopliteal lesions was associated with acceptable stent patency and freedom from clinically driven target lesion revascularization and a low rate of stent fracture at 3 years, researchers for the DURABILITY II trial reported in Catheterization and Cardiovascular Interventions.

Researchers evaluated the long-term safety and efficacy of the single self-expanding peripheral stent system (EverFlex, Covidien) in patients with atherosclerotic disease of the superficial femoral and proximal popliteal arteries. The study included 287 patients (mean age, 68 years; 66% men; mean lesion length, 8.9 cm). Of those, the researchers reported 3-year follow-up data on 220 patients.

In the Journals

OSA may predict serious adverse outcomes following stroke, IHD

March 30, 2015
Obstructive sleep apnea appears to be linked with an increased risk for stroke, ischemic heart disease, and all-cause mortality among patients following vascular events…
FDA News

New administration option for ticagrelor now approved

March 30, 2015
For patients with ACS who are unable to swallow whole tablets, ticagrelor is now approved by the FDA to be crushed and administered in water by swallowing or via…
Sabina Murphy Meeting News Coverage

IMPROVE-IT: Ezetimibe plus simvastatin reduces total, recurrent CV events

March 30, 2015
SAN DIEGO — High-risk patients with ACS assigned simvastatin plus ezetimibe had fewer total and recurrent events compared with those assigned simvastatin alone…
Jagat Narula, MD, PhD

Jagat Narula, MD, receives ACC Distinguished Scientist Award

March 29, 2015
The American College of Cardiology presented Jagat Narula, MD, PhD, MACC, associate dean for global affairs at Icahn School of Medicine at Mount Sinai and…
More News Headlines »
CME
Best of Lipid Forum III

Best of Lipid Forum III

This activity is supported by an educational grant from Amgen, Inc.

Appropriate therapies for various dyslipidemias remain a challenge for practitioners struggling to reduce residual risk…
More »
Meeting News Coverage Video
thumbnail for video 4136459899001

VIDEO: PEGASUS-TIMI 54 suggests benefit of long-term DAPT

March 26, 2015
SAN DIEGO — In this video, Deepak L. Bhatt, MD, MPH, Chief Medical Editor of Cardiology Today's Intervention…
More »
CME
Severe Hypertriglyceridemia: Confronting the Complex Issues in Etiology and Treatment

Severe Hypertriglyceridemia: Confronting the Complex Issues in Etiology and Treatment

This activity is supported by an educational grant from AstraZeneca.

Hypertriglyceridemia is a highly prevalent, yet modifiable, risk factor for atherosclerotic disease, pancreatitis, and…
More »
morganatic-roan